← Back to Search

Diagnostic Test

Intervention Group for Inflammatory Bowel Disease (IBDDysplasia Trial)

N/A
Waitlist Available
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

IBDDysplasia Trial Summary

This trial aims to compare the safety and effectiveness of targeted biopsies (looking only at areas that seem abnormal) versus targeted plus random biopsies (also taking a small sample from a healthy-looking area) in people with IBD.

Eligible Conditions
  • Inflammatory Bowel Disease
  • Colorectal Cancer
  • Dysplasia

IBDDysplasia Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events occurrence
Overall Number of Participants Enrolled
Rate of Protocol Adherence
+1 more
Secondary outcome measures
Rate of Missed 2-Week Post-Procedural Assessment for Complications
Rate of Study Variables

IBDDysplasia Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants will undergo standard colonoscopy as part of their routine IBD surveillance. During this colonoscopy targeted biopsies (biopsies of any pre-cancerous lesions observed by the doctor) and/or removal of any polyps will be undertaken.
Group II: Control GroupExperimental Treatment1 Intervention
Participants will undergo standard colonoscopy as part of their routine IBD surveillance. During this colonoscopy both random (approximately 32 to 40) and targeted biopsies (and/or removal of any polyps) will be undertaken.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention Group
2020
Completed Phase 2
~7240
Control Group
2012
Completed Phase 2
~2470

Find a Location

Who is running the clinical trial?

Western University, CanadaOTHER
239 Previous Clinical Trials
56,883 Total Patients Enrolled
Thunder Bay Regional Health Sciences CentreOTHER
9 Previous Clinical Trials
2,910 Total Patients Enrolled
University of TorontoOTHER
690 Previous Clinical Trials
1,019,043 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Alabama
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
IBD Neoplasia Surveillance Pilot RCT
2020. "IBD Neoplasia Surveillance Pilot RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04067778.
~136 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top